Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04971278 · ClinicalTrials.gov registry record

Evaluating the Impact of a Supportive Care Program

A clinical trial of Patient Engagement and Morality, sponsored by NYU Langone Health.

Completed
Registry status
1,201
Enrollment target
1
Study location

NCT04971278: Completed study of Patient Engagement and Morality, sponsored by NYU Langone Health.

NCT04971278 is a study of Patient Engagement and Morality that has completed, run by NYU Langone Health. The registered enrollment target is 1,201 participants, above the 189-participant average among 6 other Patient Engagement trials with a reported enrollment target (535% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04971278, a study of Patient Engagement and Morality, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
1,201 participants
Enrollment target
1
Study location

Study Summary

NYU's High Risk Program targets patients who may be more likely to have increased hospitalization due to health conditions that may cause death in the near future. Community Health Workers, a home visiting doctor service, a supportive care nurse, and behavioral health specialist engage the population to address a range of biopsychosocial needs with end goal in increasing support in the community and engaging palliative and hospice care when appropriate to prevent hospital readmissions, shorten length of stay, reduce hospital utilization, and decrease overall patient cost with a focus on hospital spend.

Primary Outcome

How many and how often are ACP notes written for patients

Interventions

  • BEHAVIORAL Supportive care program

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 1,201 participants
Start Date 2019-11-07
Est. Completion 2022-09-22
NYU Langone Health

1,164 total trials

What the finished NCT04971278 record still lists

NCT04971278 is an observational study that tracks outcomes without assigning an intervention. Its 1,201 participants enrollment target places it among the larger protocols in the corpus, above the 189-participant average among 6 other Patient Engagement trials with a reported enrollment target (535% higher).

The record links to 2 conditions, with Patient Engagement appearing as the primary indexed condition, and to 1 intervention - of which Supportive care program is the first listed.

NCT04971278 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04971278 about?

NCT04971278 is a clinical study titled "Evaluating the Impact of a Supportive Care Program". NYU's High Risk Program targets patients who may be more likely to have increased hospitalization due to health conditions that may cause death in the near future. Community Health Workers, a home visiting doctor service, a supportive care nurse, and behavioral health specialist engage the populatio...

What is the current status of trial NCT04971278?

This trial is currently completed. The enrollment target is 1,201 participants. The study started on 2019-11-07. Estimated completion is 2022-09-22.

What conditions does trial NCT04971278 study?

This clinical trial studies the following conditions: Patient Engagement, Morality.

What interventions are being tested in trial NCT04971278?

The interventions under investigation include: Supportive care program (BEHAVIORAL).

Who is sponsoring clinical trial NCT04971278?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04971278 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patient Engagement

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001987 · 1,200 participants

    Genetic Studies of Insulin and Diabetes

  • NCT00477100 · 1,200 participants

    Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

  • NCT01209000 · 1,200 participants

    Nephrotic Syndrome Study Network

  • NCT01944332 · 1,200 participants · NA

    Gamete Treatment to Correct Fertilization Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04971278, the US trial registry maintained by the National Library of Medicine. NCT04971278 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.